Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Treatment of addiction and addiction-related behavior

Patent ·
OSTI ID:1175166

The present invention provides a highly efficient method for treating substance addiction and for changing addiction-related behavior of a mammal suffering from substance addiction. The method includes administering to a mammal an effective amount of gamma vinylGABA or a pharmaceutically acceptable salt thereof. The present invention also provides a method of treatment of cocaine, morphine, heroin, nicotine, amphetamine, methamphetamine, or ethanol addiction by treating a mammal with an effective amount of gamma vinylGABA or a pharmaceutically acceptable salt thereof.

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-98CH10886
Assignee:
Brookhaven Science Associates (Upton, NY)
Patent Number(s):
6,828,349
Application Number:
09/189,166
OSTI ID:
1175166
Country of Publication:
United States
Language:
English

References (51)

Chemically Modified Oligonucleotides as Probes and Inhibitors journal June 1991
Facile methods to recycle nucleosides during solid phase synthesis of oligonucleotides journal May 1994
Carbohydrates: Synthetic Methods and Applications in Antisense Therapeutics book December 1994
Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area journal January 1994
Detritylation of mono- and di-saccharide derivatives using ferric chloride hydrate journal October 1997
On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. journal July 1988
Stepwise Regeneration and Recovery of Deoxyribonucleoside Phosphoramidite Monomers During Solid-Phase Oligonucleotide Synthesis journal April 1994
DNA with Altered Backbones in Antisense Applications book January 1999
Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure journal June 1997
Pharmacological treatment of tobacco dependence journal May 1988
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity journal April 1997
Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen journal December 1990
Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine-Treated Rats journal April 1997
Use of the naphthalene radical ion in deblocking O-methoxytrityl nucleotide derivatives journal January 1975
Infusion of Nicotine in the Ventral Tegmental Area or the Nucleus Accumbens of the Rat Differentially Affects Accumbal Dopamine Release journal December 1994
The use of zinc bromide for removal of dimethoxytrityl ethers from deoxynucleosides journal January 1980
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation journal October 1997
Gamma-Vinyl GABA Decreases Voluntary Alcohol Consumption in Alcohol-Preferring AA Rats journal September 1993
Cigarette smokers self-administer intravenous nicotine journal November 1983
Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats journal October 1996
Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis journal June 1984
Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice journal June 1998
Basic aspects of GABA-transmission in alcoholism, with particular reference to GABA-transaminase journal February 1997
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats journal December 1986
Striatal binding of the PET ligand11C-raclopride is altered by drugs that modify synaptic dopamine levels journal April 1993
Imaging endogenous dopamine competition with [11C]raclopride in the human brain journal April 1994
Vigabatrin: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Epilepsy and Disorders of Motor Control journal January 1991
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. journal December 1993
Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds journal October 1997
Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward journal May 1995
Selective deprotection by reductive cleavage with radical anions journal November 1975
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. journal July 1988
Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats journal October 1996
Place Conditioning: A Simple and Effective Method for Assessing the Motivational Properties of Drugs book January 1987
Nicotine Dependence, Midbrain Dopamine Systems and Psychiatric Disorders journal March 1995
Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects journal September 1990
Apparent absence of nicotine-induced conditioned place preference in rats journal May 1987
Treatment of Cocaine Abuse: Pharmacotherapy
  • Kleber, Herbert D.
  • Ciba Foundation Symposium 166 ‐ Cocaine: Scientific and Social Dimensions: Cocaine: Scientific and Social Dimensions: Ciba Foundation Symposium 166 https://doi.org/10.1002/9780470514245.ch11
book September 2007
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography journal October 1992
Control of behavior by intravenous nicotine injections in human subjects journal December 1983
?-VINYL GABA (4-amino-hex-5-enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA-T: EFFECTS ON BRAIN GABA METABOLISM IN MICE journal November 1977
Self-administration in rats allowed unlimited access to nicotine journal October 1997
The triphenylmethyl (trityl) group and its uses in nucleotide chemistry journal January 1980
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs journal July 1996
Amphetamine and vigabatrin down regulate aromatic l-amino acid decarboxylase mRNA levels journal January 1996
Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens journal September 1989
A novel strategy for the treatment of cocaine addiction journal October 1998
Selective hydrogenations promoted by copper catalysts. 1. Chemoselectivity, regioselectivity, and stereoselectivity in the hydrogenation of 3-substituted steroids journal June 1991
Pharmacologic characterization of nicotine-induced conditioned place preference journal February 1985
Selective Electrochemical Removal of Protecting Groups in Nucleotide Synthesis journal February 1979
Perkin communications. 4,4′-Dimethoxytrityl and 4-monomethoxytrityl tetrafluoroborate: convenient reagents for the protection of primary alcohols including sugars journal January 1990

Similar Records

Treatment of addiction and addiction-related behavior
Patent · Tue Dec 31 23:00:00 EST 2002 · OSTI ID:875138

Treatment of addiction and addiction-related behavior
Patent · Fri Dec 31 23:00:00 EST 1999 · OSTI ID:872977

Treatment of addiction and addiction-related behavior
Patent · Tue May 02 00:00:00 EDT 2000 · OSTI ID:20050617

Related Subjects